Company intelligence / Profile preview

Neurohacker Collective

Carlsbad, California, United Statesfacebook.com ↗

Ownership: Private
Employees: ~32
Development stage: Other

Overview

Neurohacker Collective’s products—including the flagship Qualia Mind—are commercially available dietary supplements designed to support cognitive performance and overall well-being. The company uses a systems-based approach to formulation but does not conduct traditional clinical trials typical of pharmaceutical development. Some ingredients have supporting research for efficacy in cognition or sleep; however, no large-scale clinical results specific to their proprietary blends have been published.

Therapeutic areas: Neurology
Modalities: Small moleculeNon-pharmacological therapy
Industry: Food & Nutrition

Partnerships

none publicly disclosed

Beyond the preview

Go deeper on Neurohacker Collective.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurohacker Collective.

Explore the full profile